Molecular Biomarkers Workshop: A European strategy for developing lung cancer molecular diagnostics in high risk populations

Lung Cancer

Volumn 31, Issue 2-3, 2001, Pages 339-345

  Field, J K ^a   Brambilla, C ^b   Hirsch, F R ^c   Hittelman, W ^d   Hogan, M ^e   Marshall, D ^f   Mulshine, J L ^g   Rabbitts, P ^h   Sutedja, T ⁱ   Watson, A ^j   Weiss, S ^f  

^a Lung Cancer Research   (United Kingdom)

^b GRENOBLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF COLORADO   (United States)

^d EAST TEXAS MEDICAL CENTER   (United States)

^e Genometrix Inc   (United States)

^f BAYER CORPORATION   (United States)

^g NATIONAL CANCER INSTITUTE   (United States)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^j UNIVERSITY OF LIVERPOOL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CANCER DIAGNOSIS; CANCER SCREENING; CHEMOPROPHYLAXIS; CONFERENCE PAPER; EUROPE; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; LUNG CANCER; MOLECULAR BIOLOGY; PRIORITY JOURNAL; WORKSHOP;

EID: 0035143239     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00236-1     Document Type: Conference Paper

References (0)